RareResearch.AI
← Back to atlas

A48V

Category 5 — IDR ExclusionConflictingCytoplasmic · predictedSource card
AlanineValine at position 48 · N-term IDR (1-86) · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type A48 — native residue, no strong sidechain contacts
Fullscreen ↗
DynaMut2 mutant · A48V
Mutant V48 — energy-minimized; local contact network preserved
Fullscreen ↗

Computational Predictions

DynaMut2 ΔΔG
-0.75kcal/mol
Destabilising_but_UNTRUSTED_IDR — mild
AlphaMissense
0.075
LBen
AlphaFold pLDDT
25
model confidence
Schema
Cat 5
Category 5 — IDR Exclusion

Clinical Evidence

ClinVar classificationConflicting classifications of pathogenicity
Review statuscriteria provided, conflicting classifications
Associated conditionsInborn genetic diseases; not specified; not provided
Population frequency (gnomAD v4)Ultra-rare · AF 0.00076%
cDNA changec.143C>T
ClinVar accessionVCV000045435
Last evaluated2025/12/20 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — A48V Variant Card

Molecular Atlas Pilot Variant · RareResearch.AI · Windsor Symposium Demo

Prepared: May 26, 2026 · Schema target: Category 5 — IDR EXCLUSION


Identity

FieldValue
VariantA48V
DNA changec.143C>T
GeneWFS1
ProteinWolframin (890 aa)
UniProt IDO76024
ClinVar accessionVCV000045435
Amino acid changeA → V at position 48

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 4825.08
DomainN-terminal intrinsically disordered region (1-86)
UniProt features at this position
  • Chain: 1-890 Wolframin
  • Region: 1-321 Interaction with ATP6V1A
  • Region: 1-86 Disordered

Position 48, pLDDT 25.08. This residue belongs to wolframin's disordered N-terminal region (residues 1–86), annotated by UniProt as the ATP6V1A interaction region but lacking defined secondary structure. AlphaFold's confidence is below the IDR threshold of 50 — meaning the model is essentially a guess about local geometry.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.0750
am_classLBen
InterpretationLikely benign per AlphaMissense

DynaMut2

FieldValue
Job ID177985960542
ΔΔG (kcal/mol)-0.75 kcal/mol (Destabilising)
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/177985960542

Clinical Evidence

FieldValue
ClinVar classificationConflicting classifications of pathogenicity
Review statuscriteria provided, conflicting classifications
Last evaluated2025/12/20 00:00
Associated conditionsInborn genetic diseases; not specified; not provided; Wolfram syndrome 1

Computational vs Clinical Tension

AlphaMissense 0.075 (LBen — Likely Benign). ClinVar shows Conflicting classifications of pathogenicity — submitting labs cannot agree. Some call it Wolfram syndrome 1; others call it benign. The Atlas resolves this tension by refusing to take a structural position: in an IDR, structure-based predictions are unreliable, and the variant must be triaged to wet-lab functional validation (cell-based assays, family segregation, RNA effects).


Phenotype focus

Reported in Wolfram syndrome 1 by some submitters; benign by others — clinical signal unresolved

Carrier story

A48V is a litmus test for the Atlas's intellectual honesty. It sits at position 48 in the N-terminal intrinsically disordered region, pLDDT 25.08 — deep in the floppy zone where no static model can support reliable structure-function inference.

Mechanism hypothesis

If DynaMut2 returns any specific ΔΔG, that value is not trustworthy for a low-pLDDT residue — DynaMut2 assumes a meaningful starting structure. The correct schema output for A48V is Category 5 — exclude from druggability prediction; flag for experimental validation only. This is the Atlas saying 'I don't know — and here's why.'


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • A48V_molstar_viewer.html — interactive 3D viewer (auto-loads and highlights position 48)
  • A48V_variant_card.md — this card
  • A48V_variant_card.html — demo-ready styled version

Final Schema Categorization

Category 5 — IDR EXCLUSION (DynaMut2 result is NOT trustworthy)

DynaMut2 returned a routine-looking -0.75 kcal/mol. That number should not be used clinically. The starting AlphaFold structure at position 48 has pLDDT 25.08 — well below the 50 threshold below which the model's local geometry is essentially noise. DynaMut2 assumes a meaningful input structure; for IDR residues that assumption is violated. Combined with AlphaMissense 0.075 (benign) and ClinVar's Conflicting clinical classifications, A48V is the Atlas's textbook 'I don't know — route to wet-lab' case. The schema's intellectual honesty matters most here.


Every assumption documented. Every score sourced. The Atlas standard.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the A48V PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download A48V PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.